1006 related articles for article (PubMed ID: 22755423)
41. Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
Gruessner A; Sutherland DE
Clin Transpl; 1996; ():47-67. PubMed ID: 9286558
[TBL] [Abstract][Full Text] [Related]
42. UNOS Registry data: effect of transfusions.
Cicciarelli J
Clin Transpl; 1990; ():407-16. PubMed ID: 2103162
[TBL] [Abstract][Full Text] [Related]
43. Refinement of permissible HLA mismatches.
Takemoto S; Terasaki PI
Clin Transpl; 1994; ():451-66. PubMed ID: 7547575
[TBL] [Abstract][Full Text] [Related]
44. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
45. Effect of HLA matching on renal transplant survival.
Zhou YC; Cecka JM
Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
[TBL] [Abstract][Full Text] [Related]
46. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
47. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
48. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
Berardinelli L; Raiteri M; Beretta C; Pasciucco A; Giussani A; Carini M; Marenghi C; Rossetti A; Piccolo G
Clin Transpl; 2011; ():99-110. PubMed ID: 22755406
[TBL] [Abstract][Full Text] [Related]
49. Lack of impact of human leukocyte antigen matching in living donor kidney transplantation: experience at Akdeniz University.
Tuncer M; Gurkan A; Erdogan O; Yucetin L; Demirbas A
Transplant Proc; 2005 Sep; 37(7):2969-72. PubMed ID: 16213277
[TBL] [Abstract][Full Text] [Related]
50. Significance of the donor age effect on kidney transplants.
Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
[TBL] [Abstract][Full Text] [Related]
51. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
[TBL] [Abstract][Full Text] [Related]
52. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
[TBL] [Abstract][Full Text] [Related]
53. The OPTN/UNOS Renal Transplant Registry 2003.
Cecka JM
Clin Transpl; 2003; ():1-12. PubMed ID: 15387094
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
[TBL] [Abstract][Full Text] [Related]
55. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
56. The OPTN/UNOS renal transplant registry.
Cecka JM
Clin Transpl; 2004; ():1-16. PubMed ID: 16704134
[TBL] [Abstract][Full Text] [Related]
57. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
Tran TH; Döhler B; Heinold A; Scherer S; Ruhenstroth A; Opelz G
Transplantation; 2011 Aug; 92(4):419-25. PubMed ID: 21743387
[TBL] [Abstract][Full Text] [Related]
58. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
59. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
[TBL] [Abstract][Full Text] [Related]
60. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
